Latest news with #forLife
The Herald Scotland
11-08-2025
- The Herald Scotland
Police catch £38k cocaine handover in Paisley graveyard
Andrew Crossey had been the target of surveillance and he was clocked leaving his home in his white Audi on May 2. The 42 year-old pulled up in the town's Hawkhead Cemetery. Associate Sean Teesdale turned up in a BMW. The 28 year-old briefly got into Crossey's motor before returning to his own and driving off. Prosecutor David McLean told the High Court in Glasgow that tracking police then tried to stop Teesdale at traffic lights in the city's Nitshill. Read More But, he drove off and was spotted chucking items out of the car window. Teesdale was, however, finally halted – a total of £1605 of cash was initially discovered in the motor. The discarded packages were also collected and found to be cocaine with a purity of 81 per cent. The haul had a potential value of around £38,000. Teesdale generally made no comment when quizzed, but did state: 'Wrong place at wrong time - I should not have been there and that is that.' Fingerprints linked both him and Crossey to the consignment. Police meantime kept Crossey under watch – he was seen on May 11 with a yellow 'Bag for Life' and then getting into a white Mercedes van. He was later clocked in Paisley where 32 year-old Gary McGhee got in the vehicle and then left with the bag. McGhee went into a property in the Shortroods area of the town where police then swooped. Officers checked the house, found the bathroom locked before McGhee opened its door. Mr McLean: 'They immediately saw the yellow 'Bag for Life' on the floor along with what appeared to be blocks of controlled drugs later identified as cocaine as well as a large black handled kitchen knife.' The drugs had a purity of up to almost 80 per cent. The court heard the stash had a potential value of around £500,000. Forensic evidence again helped pin the traffickers to this haul. Crossey, of Paisley, admitted to two drug supply charges with McGhee, also of the town, and Teesdale, of Stewarton, Ayrshire, one each. Lady Ross deferred sentencing for reports until a later date.
Glasgow Times
10-08-2025
- Glasgow Times
More than £500,000 of cocaine seized including from drugs handover
Officers had carried out two raids within days of each other in Paisley, Renfrewshire, in 2023. Andrew Crossey had been the target of surveillance, and he was clocked leaving his home in his white Audi on May 2. The 42-year-old pulled up in the town's Hawkhead Cemetery. Associate Sean Teesdale turned up in a BMW. READ MORE: Children in 'total shock' after being evacuated from Glasgow home amid blaze READ MORE: Nurse in the dock after verbal 'rammy' at school gates The 28-year-old briefly got into Crossey's motor before returning to his own and driving off. Prosecutor David McLean told the High Court in Glasgow that tracking police then tried to stop Teesdale at traffic lights in the city's Nitshill. But, he drove off and was spotted chucking items out of the car window. Teesdale was, however, finally halted – a total of £1605 of cash was initially discovered in the motor. The discarded packages were also collected and found to be cocaine with a purity of 81 per cent. The haul had a potential value of around £38,000. Teesdale generally made no comment when quizzed, but did state: 'Wrong place at wrong time - I should not have been there and that is that.' READ MORE: Man's body found in wooded area of busy park Fingerprints linked both him and Crossey to the consignment. Police, meantime, kept Crossey under watch – he was seen on May 11 with a yellow 'Bag for Life' and then getting into a white Mercedes van. He was later clocked in Paisley, where 32-year-old Gary McGhee got in the vehicle and then left with the bag. McGhee went into a property in the Shortroods area of the town, where police then swooped. Officers checked the house, found the bathroom locked before McGhee opened its door. Mr McLean: 'They immediately saw the yellow 'Bag for Life' on the floor along with what appeared to be blocks of controlled drugs, later identified as cocaine, as well as a large black handled kitchen knife.' The drugs had a purity of up to almost 80 per cent. The court heard the stash had a potential value of around £500,000. Forensic evidence again helped pin the traffickers to this haul. Crossey, of Paisley, admitted to two drug supply charges with McGhee, also of the town, and Teesdale, of Stewarton, Ayrshire, one each. Lady Ross deferred sentencing for reports until a later date.
Yahoo
07-08-2025
- Health
- Yahoo
My scar makes beach outings an ordeal. How can I care less about it?
Hi Ugly, I've had a keloid scar in the middle of my chest since my teen years, when I had . (I'm now in my mid-forties.) It started off small, but is now about 5cm long, 1cm high and a few millimeters raised off my skin. It sometimes itches or feels tight and painful, but otherwise is just an unattractive inconvenience. Having said that, it's had a horrible and disproportionate impact on my confidence. Is there any way to reduce the redness or the size, or stop it from growing? Secondly, and perhaps more importantly, what mindset should I take to reduce its importance, so that going to the swimming pool or beach is less of an ordeal? – Scarred for Life Have you been to the beach or the pool, Scarred for Life? I'm not asking if you've seen a beach scene in a movie or a commercial that takes place poolside. Have you been to an actual beach or pool, populated by actual people? Maybe you've been too preoccupied with your scar to notice: almost everybody has a weird body! By 'weird', of course, I mean normal; the hyper-perfection of Hollywood is the real statistical anomaly. A sampling of features I scoped on my own recent beach outing: fat rolls, congenital moles and cellulite. Acne. Assne. Double chins, triple chins, chin hairs glistening in the sunlight. Sagging, wrinkling and/or jiggling skin. Pubic hair stubble. Top surgery scars, caesarean section scars and, yes, keloid scars. And I didn't have to look very hard. Keloids – thick, raised scars that have 'grown outside of the boundaries of the original wound', according Dr Michelle Henry, a board-certified dermatologist based in New York – affect an estimated 10% of the world's population. That's 800 million people, or more than double the US population. 'We see keloids more often in patients of African descent and Asian descent, but really, we see them in everyone,' Henry tells me. They are most likely to form on the chest or back, and indicate a sort of haywire healing response. When skin starts to repair a wound – a pimple, a scrape, a surgical incision – it sends collagen to the site to create scar tissue. 'There are different checks and balances to tell the body when to stop laying down collagen, but with keloids, that goes unchecked,' Henry explains. (I generally try to avoid glorifying youthfulness, but here's a fun fact to assuage some of your insecurity, Scarred: Henry says those prone to keloids may 'age better', cosmetically speaking, due to all that collagen.) These scars can feel itchy, tight and uncomfortable as they grow. Potential treatments include steroid injections, targeted radiation, cryotherapy and Botox to reduce size, as well as laser therapy to reduce redness. 'Sometimes we do excise them,' Henry adds, 'but that's a very careful process, because you can end up with a scar that's bigger than the original keloid.' You can consult a dermatologist to see if any of these options might work for you – but if you're looking for something more low-key to try at home, Henry says silicone gels or patches can help. Related: Tell us: share your experiences of traveling with friends That said, keloids don't require treatment. They're benign. They don't pose a threat to your physical health, especially on your chest; medical intervention might be recommended if the scar were, say, close to your eye and affecting your vision, or on the back of your knee and affecting your movement. It's your mental health that needs attention right now. My recommendation, besides deriving confidence from within – who you are, what you value and how you treat people? Recalibrate your concept of averageness. Averageness is 'the most important aspect' of one's understanding of beauty, said Dr Neelam Vashi, an associate professor of dermatology at Boston University's medical school, on the Apple News in Conversation podcast. It refers to how closely any given face or body matches that of the average person within their population. 'Our population could be me looking at 1,000 images,' Dr Vashi explained. 'What my brain does is looks at all of them, and then it makes a prototype [of beauty] in my head.' More from Jessica DeFino's :Thanks to the prevalence of filters, photo-editing technology and AI-generated imagery, people's prototypes now reference digitally altered inputs, said Vashi. This means scarred, middle-aged skin might not fit your brain's idea of attractiveness, or even normality. The good news: brains are malleable! Vashi cited a 2009 study in which researchers squished and stretched the faces of storybook characters and found that, after viewing altered images, children's sense of what was beautiful subtly shifted toward the distortions. So start with some amateur exposure therapy. Go to the beach! Go to the pool! Go to a communal spa or a nude spa (Korean spas, known as jjimjilbangs, are my personal happy place). Notice different bodies, faces, skin types, textures – not to compare, judge or objectify, but to observe. Take it to the virtual realm: follow influencers with keloid scars on Instagram or TikTok. Watch the latest seasons of The Ultimatum: Queer Love and Love Island UK; both feature bikini-clad contestants with visible keloids. This will all help adjust your internal prototype. You say your scar is 'unattractive'. I hope that working through this gets you closer to neutrality. You don't have to find your scar beautiful to be confident. Just realize that your body is like any other: bizarre and inconsistent and specific and alive, and worthy of a nice day at the beach. Callout
Yahoo
12-06-2025
- Business
- Yahoo
The Lovesac Company Reports First Quarter Fiscal 2026 Financial Results
Q1 FY26 Net Sales Increased 4.3% to $138.4 Million vs. Q1 FY25 STAMFORD, Conn., June 12, 2025 (GLOBE NEWSWIRE) -- The Lovesac Company (Nasdaq: LOVE) ('Lovesac' or the 'Company'), the Designed for Life home and technology brand best known for its Sactionals, The World's Most Adaptable Couch, today announced financial results for the first quarter of fiscal 2026, which ended May 4, 2025. Shawn Nelson, Chief Executive Officer, stated, 'Our first quarter performance was inline with our expectations to capitalize on secular initiatives to drive growth. Notably, we delivered topline growth and leveraged operating expenses as we have begun to reap the benefits of previous investments in core capabilities to bolster our infinity flywheel and accelerate our pace of product innovation. Our first quarter also reflected another period of market share gains despite persistent category headwinds and an evolving macroeconomic backdrop, thereby reinforcing our unique competitive advantages driven by our Designed for Life product platforms and efficient customer acquisition engines. As we enter the second quarter, we are thrilled to have launched our third Designed For Life Platform, EverCouch. This expansion into the armchair, loveseat and sofa category effectively doubles our total addressable market. While we remain cautious given the dynamic environment, we have high conviction in our long-term growth trajectory as we execute against our strategic roadmap and unlock the tremendous growth potential ahead.' Key Measures for the First Quarter of Fiscal 2026 Ending May 4, 2025:(Dollars in millions, except per share amounts. Dollar and percentage changes may not recalculate due to rounding.) Thirteen weeks ended May 4,2025 May 5,2024 % Inc (Dec) Net sales Showrooms $96.5 $81.6 18.2% Internet $33.3 $36.6 (8.9%) Other $8.6 $14.4 (40.5%) Total net sales $138.4 $132.6 4.3% Gross profit $74.4 $72.0 3.2% Gross margin 53.7% 54.3% (60) bps Total operating expenses $89.3 $89.9 (0.6%) SG&A $67.1 $68.4 (1.9%) SG&A as a % of Net Sales 48.5% 51.6% (310) bps Advertising and marketing $18.6 $18.0 3.3% Advertising & marketing as a % of Net Sales 13.4% 13.6% (20) bps Net loss $(10.8) $(13.0) 16.4% Basic net loss per common share $(0.73) $(0.83) 12.0% Diluted net loss per common share $(0.73) $(0.83) 12.0% Adjusted EBITDA1 $(8.4) $(10.3) 17.7% Net cash used in operating activities $(41.4) $(7.0) (489.9%) 1 Adjusted EBITDA is a non-GAAP measure. See 'Non-GAAP Information' and 'Reconciliation of Non-GAAP Financial Measures' included in this press release. Percent increase (decrease) except showroom count Thirteen weeks ended May 4,2025 May 5,2024 Omni-channel Comparable Net Sales(1) 2.8% (14.8)% Internet Sales (8.9)% (9.0)% Ending Showroom Count 267 246 1 Omni-channel Comparable Net Sales includes sales at all retail locations and online, open greater than 12 months (including remodels and relocations) and excludes closed stores. Highlights for the Quarter Ended May 4, 2025: Net sales increased $5.8 million, or 4.3%, in the first quarter of fiscal 2026 compared to the prior year period primarily driven by an increase of 2.8% in omni-channel comparable net sales and the net addition of 21 new showrooms. During the first quarter of fiscal 2026, we opened 11 additional showrooms and closed 1 showroom. Gross profit increased $2.4 million, or 3.2% in the first quarter of fiscal 2026 compared to the prior year period. Gross margin decreased 60 basis points to 53.7% of net sales in the first quarter of fiscal 2026 from 54.3% of net sales in the prior year period primarily driven by a decrease of 230 basis points in product margin driven by higher promotional discounting, partially offset by decreases of 130 basis points in inbound transportation costs and 40 basis points in outbound transportation and warehousing costs. SG&A expense decreased $1.3 million, or 1.9%, in the first quarter of fiscal 2026 compared to the prior year period due to decreases in professional fees, insurance matters, credit card fees, computer expense, and other overhead costs, partially offset by increases in payroll, equity-based compensation, and rent. Advertising and marketing expense increased $0.6 million, or 3.3% in the first quarter of fiscal 2026 compared to the prior year period, primarily driven by costs associated with the launch of a new product marketing campaign. Operating loss was $15.0 million in the first quarter of fiscal 2026 compared to $17.9 million in the prior year period. Operating margin was (10.8)% of net sales in the first quarter of fiscal 2026 compared to (13.5)% of net sales in the prior year period. Net loss was $10.8 million in the first quarter of fiscal 2026 or $(0.73) net loss per common share compared to $13.0 million or $(0.83) net loss per common share in the prior year period. During the first quarter of fiscal 2026, the Company recorded an income tax benefit of $3.8 million, compared to $4.2 million in the prior year period. The change in benefit is primarily driven by a lower net loss before taxes. Other Financial Highlights as of May 4, 2025: The cash and cash equivalents balance as of May 4, 2025 was $26.9 million as compared to $72.4 million as of May 5, 2024. There was no balance on the Company's line of credit as of May 4, 2025 and May 5, 2024. The Company's availability under the line of credit was $36.0 million and $33.7 million as of May 4, 2025 and May 5, 2024, respectively. Total merchandise inventory was $124.9 million as of May 4, 2025 as compared to $94.7 million as of May 5, 2024 primarily related to a planned stock inventory increase of $25.9 million coupled with an increase in freight capitalization of $5.1 million. Outlook: The Company provides guidance of select information related to the Company's financial and operating performance, and such measures may differ from year to year. The projections are as of this date and the Company assumes no obligation to update or supplement this information. The Company currently expects the following for the full year of fiscal 2026: Net sales in the range of $700 million to $750 million. Adjusted EBITDA1 in the range of $48 million to $60 million. Net income in the range of $13 million to $22 million. Diluted income per common share in the range of $0.80 to $1.36 on approximately 16.3 million estimated diluted weighted average shares outstanding. The Company currently expects the following for the second quarter of fiscal 2026: Net sales in the range of $157 million to $166 million. Adjusted EBITDA1 loss in the range of $2 million to $7 million. Net loss in the range of $8 million to $12 million. Basic loss per common share in the range of $0.58 to $0.83 on approximately 14.6 million estimated weighted average shares outstanding. 1 Adjusted EBITDA is a non-GAAP measure. See 'Non-GAAP Information' and 'Reconciliation of Non-GAAP Financial Measures' included in this press release. Conference Call Information: A conference call to discuss the financial results for the first quarter ended May 4, 2025 is scheduled for today, June 12, 2025, at 8:30 a.m. Eastern Time. Investors and analysts interested in participating in the call are invited to dial (877) 407-3982 (international callers please dial (201) 493-6780) approximately 10 minutes prior to the start of the call. A live audio webcast of the conference call will be available online at A recorded replay of the conference call will be available within two hours of the conclusion of the call and can be accessed online at for 90 days. About The Lovesac Company: Based in Stamford, Connecticut, The Lovesac Company (NASDAQ: LOVE) is a technology driven company that designs, manufactures and sells unique, high quality furniture derived through its proprietary Designed for Life approach which results in products that are built to last a lifetime and designed to evolve as customers' lives do. The current product offering is comprised of modular couches called Sactionals, the Sactionals Reclining seat, premium foam beanbag chairs called Sacs, the Pillowsac™ Accent Chair, an immersive surround sound home theater system called StealthTech, and an innovative sofa seating solution called EverCouch™. As a recipient of Repreve's 7th Annual Champions of Sustainability Award, responsible production and innovation are at the center of the brand's design philosophy with products protected by a robust portfolio of utility patents. Products are marketed and sold primarily online directly at supported by a physical retail presence in the form of Lovesac branded showrooms, as well as through shop-in-shops and pop-up-shops with third party retailers. LOVESAC, DESIGNED FOR LIFE, SACTIONALS, SAC, STEALTHTECH, and THE WORLD'S MOST ADAPTABLE COUCH are trademarks of The Lovesac Company and are Registered in the U.S. Patent and Trademark Office. Non-GAAP Information: Adjusted EBITDA is defined as a non-GAAP financial measure by the Securities and Exchange Commission (the 'SEC') that is a supplemental measure of financial performance not required by, or presented in accordance with, GAAP. We define 'Adjusted EBITDA' as earnings before interest, taxes, depreciation and amortization, adjusted for the impact of certain non-cash and other items that we do not consider in our evaluation of ongoing operating performance. These items include management fees, equity-based compensation expense, write-offs of property and equipment, deferred rent, financing expenses and certain other charges and gains that we do not believe reflect our underlying business performance. We have reconciled this non-GAAP financial measure with the most directly comparable GAAP financial measure within the schedules attached hereto. Statements regarding our expectations as to fiscal 2026 Adjusted EBITDA do not include certain charges and costs. These items include equity-based compensation expense and certain other charges and gains that we do not believe reflect our underlying business performance. We are not able to provide a reconciliation of our non-GAAP financial guidance to the corresponding GAAP measures without unreasonable effort because of the uncertainty and variability of the nature and amount of these future charges and costs. This is due to the inherent difficulty of forecasting the timing of certain events that have not yet occurred and are out of the Company's control. We believe that these non-GAAP financial measures not only provide its management with comparable financial data for internal financial analysis but also provide meaningful supplemental information to investors. Specifically, these non-GAAP financial measures allow investors to better understand the performance of our business, facilitate a more meaningful comparison of our actual results on a period-over-period basis and provide for a more complete understanding of factors and trends affecting our business. We have provided this information as a means to evaluate the results of our ongoing operations alongside GAAP measures such as gross profit, operating income (loss) and net income (loss). Other companies in our industry may calculate these items differently than we do. These non-GAAP measures should not be considered as a substitute for the most directly comparable financial measures prepared in accordance with GAAP, such as net income (loss) or net income (loss) per share as a measure of financial performance, cash flows from operating activities as a measure of liquidity, or any other performance measure derived in accordance with GAAP. Non-GAAP financial measures have limitations as analytical tools, and investors should not consider them in isolation or as a substitute for analysis of the Company's results as reported under GAAP. Cautionary Statement Concerning Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other legal authority. Forward-looking statements can be identified by words such as 'may,' 'continue(s),' 'believe,' 'anticipate,' 'could,' 'should,' 'intend,' 'plan,' 'will,' 'aim(s),' 'can,' 'would,' 'expect(s),' 'expectation(s),' 'estimate(s),' 'project(s),' 'projections,' 'forecast(s)', 'positioned,' 'approximately,' 'potential,' 'goal,' 'pro forma,' 'strategy,' 'outlook' or the negative of these words or other similar terms or expressions that concern our expectations, strategy, plans, or intentions. All statements, other than statements of historical facts, included in this press release under the heading 'Outlook' and all statements regarding strategy, future operations and launch of new products, the pace and success of new products, future financial position or projections, future revenue, projected expenses, sustainability goals, prospects, plans and objectives of management are forward-looking statements. These statements are based on management's current expectations, beliefs and assumptions concerning the future of our business, anticipated events and trends, the economy and other future conditions. We may not actually achieve the plans, carry out the intentions or meet the expectations disclosed in the forward-looking statements and you should not rely on these forward-looking statements. Actual results and performance could differ materially from those projected in the forward-looking statements as a result of many factors. Among the key factors that could cause actual results to differ materially from those expressed or implied in the forward-looking statements include: business disruptions or other consequences of economic instability, recession, political instability, civil unrest, armed hostilities, natural and man-made disasters, pandemics or other public health crises, or other catastrophic events; the impact of changes or declines in consumer spending and increases in interest rates and inflation on our business, sales, results of operations and financial condition; cybersecurity and vulnerability to electronic break-ins and other similar disruptions; active pending or threatened litigation; our ability to manage and sustain our growth and profitability effectively, including in our ecommerce business, forecast our operating results, and manage inventory levels; our cash flows, changes in the market price of our common stock, global economic and market conditions and other considerations that could impact the specific timing, price and size of repurchases under our stock repurchase program or our ability to fund any stock repurchases; our ability to improve our products and develop and launch new products; our ability to successfully open and operate new showrooms; our ability to advance, implement or achieve the goals set forth in our ESG Report; our ability to realize the expected benefits of investments in our supply chain and infrastructure; disruption in our supply chain and dependence on foreign manufacturing and imports for our products; execution of our share repurchase program and its expected benefits for enhancing long-term shareholder value; our ability to acquire new customers and engage existing customers; reputational risk associated with increased use of social media; our ability to attract, develop and retain highly skilled associates and employees; system interruption or failures in our technology infrastructure needed to service our customers, process transactions and fulfill orders; any inability to implement and maintain effective internal control over financial reporting; unauthorized disclosure of sensitive or confidential information through breach of our computer system; the ability of third-party providers to continue uninterrupted service; the impact of changes in diplomatic and trade relations, as well as tariffs and the countermeasures and tariff mitigation initiatives; the regulatory environment in which we operate; our ability to maintain, grow and enforce our brand and intellectual property rights and avoid infringement or violation of the intellectual property rights of others; and our ability to compete and succeed in a highly competitive and evolving industry, as well as those risks and uncertainties disclosed under the sections entitled 'Risk Factors' and 'Management's Discussion and Analysis of Financial Condition and Results of Operations' in our most recent Form 10-K and in our Form 10-Qs filed with the Securities and Exchange Commission, and similar disclosures in subsequent reports filed with the SEC, which are available on our investor relations website at and on the SEC website at Any forward-looking statement made by us in this press release speaks only as of the date on which we make it. We disclaim any intent or obligation to update these forward-looking statements to reflect events or circumstances that exist after the date on which they were made. Investor Relations Contact:Caitlin Churchill, ICR(203) 682-8200InvestorRelations@ THE LOVESAC COMPANYCONDENSED BALANCE SHEETS(unaudited) (amounts in thousands, except share and per share amounts) May 4,2025 February 2,2025 Assets Current Assets Cash and cash equivalents $ 26,900 $ 83,734 Trade accounts receivable, net 13,022 16,781 Merchandise inventories, net 124,926 124,333 Prepaid expenses 12,977 14,807 Other current assets 3,628 6,942 Total Current Assets 181,453 246,597 Property and equipment, net 85,267 77,990 Operating lease right-of-use assets 164,272 157,750 Goodwill 144 144 Intangible assets, net 1,719 1,586 Deferred tax asset 18,914 15,277 Other assets 31,971 32,906 Total Assets $ 483,740 $ 532,250 Liabilities and Stockholders' Equity Current Liabilities Accounts payable $ 25,019 $ 51,814 Accrued expenses 42,453 51,986 Payroll payable 7,137 9,501 Customer deposits 11,639 11,250 Current operating lease liabilities 22,599 22,662 Sales taxes payable 4,218 7,897 Total Current Liabilities 113,065 155,110 Operating lease liabilities, long-term 169,037 160,361 Income tax payable, long-term 424 424 Line of credit — — Total Liabilities 282,526 315,895 Commitments and Contingencies Stockholders' Equity Preferred Stock $0.00001 par value, 10,000,000 shares authorized, no shares issued or outstanding as of May 4, 2025 and February 2, 2025. — — Common Stock $0.00001 par value, 40,000,000 shares authorized, 14,549,250 shares issued and outstanding as of May 4, 2025 and 14,786,934 shares issued and outstanding as of February 2, 2025. — — Additional paid-in capital 192,267 190,510 Accumulated earnings 8,947 25,845 Stockholders' Equity 201,214 216,355 Total Liabilities and Stockholders' Equity $ 483,740 $ 532,250THE LOVESAC COMPANYCONDENSED STATEMENTS OF OPERATIONS(unaudited) Thirteen weeks ended (amounts in thousands, except per share data and share amounts) May 4,2025 May 5,2024 Net sales $ 138,373 $ 132,643 Cost of merchandise sold 64,003 60,598 Gross profit 74,370 72,045 Operating expenses: Selling, general and administrative expenses 67,117 68,403 Advertising and marketing 18,594 17,996 Depreciation and amortization 3,613 3,502 Total operating expenses 89,324 89,901 Operating loss (14,954 ) (17,856 ) Interest and other income, net 325 744 Net loss before taxes (14,629 ) (17,112 ) Income tax benefit 3,789 4,152 Net loss $ (10,840 ) $ (12,960 ) Net loss per common share: Basic $ (0.73 ) $ (0.83 ) Diluted $ (0.73 ) $ (0.83 ) Weighted average shares outstanding: Basic 14,792,080 15,537,823 Diluted 14,792,080 15,537,823THE LOVESAC COMPANYCONDENSED STATEMENT OF CASH FLOWS(unaudited) Thirteen weeks ended (amounts in thousands) May 4,2025 May 5,2024 Cash Flows from Operating Activities Net loss $ (10,840 ) $ (12,960 ) Adjustments to reconcile net loss to cash used in operating activities: Depreciation and amortization of property and equipment 3,545 3,391 Amortization of other intangible assets 68 111 Amortization of deferred financing fees 19 36 Net loss on disposal of property and equipment 21 43 Equity based compensation 2,501 1,152 Non-cash lease expense 6,684 6,104 Deferred income taxes (3,637 ) (4,185 ) Change in operating assets and liabilities: Trade accounts receivable 3,759 6,287 Merchandise inventories (593 ) 3,727 Prepaid expenses and other current assets 5,137 (1,067 ) Other assets 935 (1,685 ) Accounts payable (27,228 ) (2,856 ) Accrued expenses and other payables (15,720 ) (5,075 ) Operating lease liabilities (6,417 ) (3,874 ) Customer deposits 389 3,837 Net cash used in operating activities (41,377 ) (7,014 ) Cash Flows from Investing Activities Purchase of property and equipment (8,577 ) (7,296 ) Payments for patents and trademarks (124 ) (8 ) Net cash used in investing activities (8,701 ) (7,304 ) Cash Flows from Financing Activities Taxes paid for net share settlement of equity awards (744 ) (356 ) Repurchases of common stock (6,000 ) — Payment of deferred financing costs (12 ) — Net cash used in financing activities (6,756 ) (356 ) Net change in cash and cash equivalents (56,834 ) (14,674 ) Cash and cash equivalents - Beginning 83,734 87,036 Cash and cash equivalents - Ending $ 26,900 $ 72,362 Supplemental Cash Flow Data: Cash paid for taxes $ — $ 10 Cash paid for interest $ 40 $ 30 Non-cash investing and financing activities: Asset acquisitions not yet paid for at period end $ 519 $ 2,142 Leasehold improvements acquired through lease incentive $ 1,824 $ — Excise tax on share repurchases, accrued but not paid $ 58 $ —THE LOVESAC COMPANYRECONCILIATION OF NON-GAAP FINANCIAL MEASURES(unaudited) Thirteen weeks ended (amounts in thousands) May 4,2025 May 5,2024 Net loss $ (10,840 ) $ (12,960 ) Interest income, net (327 ) (744 ) Income tax benefit (3,789 ) (4,152 ) Depreciation and amortization 3,613 3,502 EBITDA (11,343 ) (14,354 ) Equity-based compensation (a) 2,622 1,203 Loss on disposal of assets (b) 21 43 Other non-recurring expenses (c) 253 2,850 Adjusted EBITDA $ (8,447 ) $ (10,258 )(a) Represents expenses, such as compensation expense and employer taxes related to RSU equity vesting and exercises associated with stock options and restricted stock units granted to our associates and board of directors. Employer taxes are included as part of selling, general and administrative expenses on the Statements of Operations. (b) Represents loss on disposal of property and equipment. (c) Other non-recurring expenses in the thirteen weeks ended May 4, 2025 represents professional fees related to the restatement of previously issued financial statements, severance, and expenses associated with other legal matters, partially offset by benefits related to insurance proceeds. Other non-recurring expenses in the thirteen weeks ended May 5, 2024 represents professional fees related to the restatement of previously issued financial statements and severance, partially offset by benefits related to insurance proceeds and other legal in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Qatar Tribune
21-05-2025
- Health
- Qatar Tribune
Hamad Trauma Centre promotes initiative to improve safety for pedestrians, cyclists
Tribune News Network Doha The Hamad Injury Prevention Programme of Hamad Trauma Centre supported the 8th UN Global Road Safety Week, which was held from May 12 to 18. This year's theme, 'Streets for Life: #MakeWalkingSafe and #MakeCyclingSafe', underscores the critical need to improve safety for pedestrians and cyclists worldwide, as part of a broader effort to reduce road traffic injuries and fatalities. Every year, more than 1.3 million people worldwide lose their lives in road accidents, with pedestrians and cyclists accounting for a significant proportion of these casualties. In Qatar, as urban development progresses, there is a growing need to prioritise the safety of vulnerable road users, such as pedestrians and cyclists. Despite a 15 percent decrease in Hamad Trauma Centre (HTC) admissions for serious injuries, the Qatar National Trauma Registry has shown a seven percent and 39 percent increase in the number of pedestrians and cyclists admitted to the HTC from 2023 to 2024. Young children, particularly under the age of 15, and older residents, more than 55 years old, were most severely injured as pedestrians. Bicycle-related traumatic injuries, predominantly affect children, below the age of 15, and working-age males who cycle for work or leisure. The HIPP at HTC is committed to preventing unnecessary road traffic injuries [RTIs] from affecting any members of the public. During this UNGRSW, HIPP emphasises the importance of managing speed as a proven means of making our roads safer for all road users, most especially for the most vulnerable road users like pedestrians, cyclists, even children and the elderly. 'We are committed to working together with all our partners to make streets in Qatar safer for all road users, especially the most vulnerable. This year's theme provides an opportunity to reflect on the vital role we can all play in contributing to a safer road environment for pedestrians and cyclists,' said Dr. Rafael Consunji, director of the Hamad Injury Prevention Programme. 'Drivers must not drive while distracted by their mobile phones, always stop for pedestrians on crosswalks and drive under the designated speed limits. Cyclists must make themselves visible [with reflectors or blinking lights], show hand signals when turning and use bike lanes when available. Pedestrians must only cross at designated crossing zones and stay on sidewalks,' Dr. Consunji added. HIPP reaffirms its commitment to advancing evidence-based road safety policies and fostering a culture of community responsibility around safer mobility. In support of the 8th UN Global Road Safety Week, the programme endorses the campaign theme 'Streets for Life: #MakeWalkingSafe and #MakeCyclingSafe', which highlights the urgent need for safer infrastructure for pedestrians and cyclists in Qatar and around the world. 'Our goal is to align with the global mission of reducing road traffic deaths and injuries by 50 percent by 2030, and this requires sustained, collaborative action,' said Dr. Consunji. 'This year's campaign reinforces the importance of integrating safety into urban planning and policymaking to protect all road users, especially the most vulnerable.'
